Related Experiment Videos
Restlessness related to SSRI withdrawal.
1Center of Psychiatry and Neurology, Fukui Prefectural Hospital, Japan. shigehiro@p2422.nsk.ne.jp
Psychiatry and Clinical Neurosciences
|March 10, 2001
Summary
Abruptly stopping fluvoxamine may cause withdrawal symptoms like restlessness in patients. Clinicians should monitor patient adherence to prevent misinterpreting these symptoms as depression relapse or side effects.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants.
- Fluvoxamine, an SSRI, has been used in Japan for about a year.
- Previous reports indicate SSRI withdrawal symptoms, but none specific to fluvoxamine in Japan.
Observation:
- A case of a depressed patient experiencing restlessness after abrupt fluvoxamine discontinuation is reported.
- The patient's restlessness resolved upon reinitiating fluvoxamine treatment.
Findings:
- Abrupt cessation of fluvoxamine can precipitate withdrawal symptoms, such as restlessness.
- These symptoms may mimic depression relapse or medication side effects.
Implications:
- Clinicians must assess patient compliance with fluvoxamine therapy.
- Careful consideration of potential fluvoxamine withdrawal is crucial in clinical practice.
- Distinguishing withdrawal symptoms from illness relapse is essential for appropriate patient management.